Literature DB >> 1706584

The fasciovascular pedicle for revascularization of other tissues.

K C Tark1, R K Khouri, K S Shin, W W Shaw.   

Abstract

A fasciovascular pedicle based on the epigastric vessels was developed in a rat model to determine if it could be used as a "universal carrier" to revascularize a new composite flap. The effects of time course, carrier size, and flap ischemia on the revascularization process were studied. A 2.5 x 4-cm or 1 x 4-cm fascial patch pedicled on the vessels was transferred under bipedicled 2.5 x 4-, 6-, or 8-cm abdominal panniculocutaneous flaps. At different time intervals, the flap was raised as an island flap connected only by it vascular bundle and then sutured back in place. The skin perfusion by dermofluorometry and flap survival were both markedly increased on day 5 (p less than 0.001). The wide carrier had a 93% survival area, whereas the narrow carrier had only 71%. The wide carrier induced relatively faster and better revascularization (p less than 0.05). Moderate ischemia promoted revascularization (p less than 0.01). An india ink injection study and histological examination provided visual evidence of revascularization. This fasciovascular pedicle is a promising model for prefabrication of complex new composite flaps and for studying the process of revascularization between the layers. Based on these findings and further investigations, a thin, prefabricated abdominal free flap was successfully transferred for facial resurfacing in humans.

Entities:  

Mesh:

Year:  1991        PMID: 1706584     DOI: 10.1097/00000637-199102000-00007

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  1 in total

1.  Revascularization of the testis using a vascular induction technique: a potential approach for staged orchiopexy in high-undescended testis.

Authors:  Ali Riza Erçöçen; Kazutaka Soejima; Hiroyuki Sakurai; Sibel Yenidünya; Yuji Kikuchi; Motohiro Nozaki
Journal:  Urol Res       Date:  2003-12-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.